Increase of sentinel lymph node melanoma staging in The Netherlands; still room and need for further improvement

Eric A. Deckers, Marieke W. J. Louwman, Schelto Kruijff, Harald J. Hoekstra*

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

7 Citaten (Scopus)
63 Downloads (Pure)


Aim: To investigate implementation of the seventh American Joint Committee on Cancer melanoma staging with sentinel lymph node biopsy (SLNB) and associations with socioeconomic status (SES). Patients & methods: Data from The Netherlands Cancer Registry on patient and tumor characteristics were analyzed for all stage IB-II melanoma cases diagnosed 2010-2016, along with SES data from The Netherlands Institute for Social Research. Results: The proportion of SLNB-staged patients increased from 40% to 65% (p <0.001). Multivariate analysis showed that being female, elderly, or having head-and-neck disease reduced the likelihood of SLNB staging. Conclusion: SLNB staging increased by 25% during the study period but lagged among elderly patients and those with head-and-neck melanoma. In The Netherlands, SES no longer affects SLNB staging performance.

Originele taal-2English
Pagina's (van-tot)27-38
Aantal pagina's12
TijdschriftMelanoma management
Nummer van het tijdschrift1
StatusPublished - mei-2020

Citeer dit